Zapanta, John Bryle J., and Charity Viado Gorospe. “Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer After Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report”. Asian Pacific Journal of Cancer Care 10, no. 3 (July 14, 2025): 989–992. Accessed May 29, 2026. http://www.waocp.com/journal/index.php/apjcc/article/view/1534.